Free Trial

Crescent Capital BDC (NASDAQ:CCAP) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Crescent Capital BDC logo with Finance background

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) issued its earnings results on Wednesday. The company reported $0.55 earnings per share for the quarter, missing analysts' consensus estimates of $0.56 by ($0.01), Zacks reports. The business had revenue of $46.40 million during the quarter, compared to the consensus estimate of $47.27 million. Crescent Capital BDC had a return on equity of 11.86% and a net margin of 37.32%.

Crescent Capital BDC Stock Down 3.3 %

Shares of Crescent Capital BDC stock traded down $0.64 during trading hours on Friday, reaching $18.42. The company's stock had a trading volume of 409,726 shares, compared to its average volume of 101,636. Crescent Capital BDC has a one year low of $16.58 and a one year high of $20.19. The company has a market capitalization of $682.50 million, a P/E ratio of 9.25 and a beta of 0.81. The stock's fifty day simple moving average is $19.43 and its two-hundred day simple moving average is $18.87. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.26 and a current ratio of 1.26.

Crescent Capital BDC Dividend Announcement

The firm also recently declared a dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 28th will be paid a dividend of $0.05 per share. The ex-dividend date is Friday, February 28th. Crescent Capital BDC's dividend payout ratio (DPR) is presently 84.42%.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. Wells Fargo & Company lowered their price objective on shares of Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating for the company in a research note on Friday. Keefe, Bruyette & Woods lifted their price target on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the company an "outperform" rating in a research note on Monday, November 25th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $19.17.

Check Out Our Latest Analysis on CCAP

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Featured Stories

Earnings History for Crescent Capital BDC (NASDAQ:CCAP)

Should You Invest $1,000 in Crescent Capital BDC Right Now?

Before you consider Crescent Capital BDC, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.

While Crescent Capital BDC currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines